Apoptosis in human papillomavirus16 E7-, but not E6-immortalized human uroepithelial cells

Oncogene

Volumn 13, Issue 6, 1996, Pages 1123-1131

  Puthenveettil, Jairaj A ^a,b   Frederickson, Susan M ^a,b   Reznikoff, Catherine A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Apoptosis; BAX; BCL 2; HPV16 E7; Human uroepithelial cells; p53

Indexed keywords

DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL IMMORTALIZATION; CELL LINE; CONTROLLED STUDY; GAMMA RADIATION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UROTHELIUM; WART VIRUS;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; EPITHELIUM; HUMANS; MUTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; URINARY TRACT;

HUMAN PAPILLOMAVIRUS TYPES;

EID: 0029809583     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Antinore MJ, Birrer MJ, Patel D, Nader L and McCance DJ. (1996). EMBO J., 15, 1950-1960.
2. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. (1995). Nature, 377, 552-557.
3. Caelles C, Helmberg A and Karin M. (1994). Nature, 370, 220-223.
4. Chen JJ, Reid CE, Band V and Androphy EJ. (1995). Science, 269, 529-531.
5. Debbas M and White E. (1993). Genes Dev., 7, 546-554.
6. Demers GW, Halbert CL and Galloway DA. (1994a). Virology, 198, 169-174.
7. Demers GW, Foster SA, Halbert CL and Galloway DA. (1994b). Proc. Natl. Acad. Sci. USA, 91, 4382-4386.
8. Dulic V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Harper JW, Elledge SJ and Reed SI. (1994). Cell, 76, 1013-1023.
9. Fritsche M, Haessler C and Brandner G. (1993). Oncogene, 8, 307-318.
10. Gorczyca W, Gong J, Ardelt B, Traganos F and Darzynkiewicz Z. (1993). Cancer Res., 53, 3186-3192.
11. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
12. Helin K, Harlow E and Fattaey. (1993). Mol. Cell. Biol., 13, 6501-6508.
13. Howes KA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM and Windle JJ. (1994). Genes Dev., 8, 1300-1310.
14. Klingelhutz AJ, Foster SA and McDougall JK. (1996). Nature, 380, 79-82.
15. Ko EJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
16. Korsmeyer SJ. (1995). TIG, 11, 101-105.
17. Kaufmann WK and Kaufman DG. (1993). FASEB J., 7, 1188-1191.
18. Lane DP. (1992). Nature, 358, 15-16.
19. La Rue H, Simoneau M and Fradet Y. (1995). Clin. Cancer Res., 1, 435-440.
20. Leonardo AD, Linke SP, Clarkin K and Wahl GM. (1994). Genes Dev., 8, 2540-2551.
21. Lowe SW and Ruley HE. (1993). Genes Dev., 7, 535-545.
22. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993a). Cell, 74, 957-967.
23. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993b). Nature, 362, 847-849.
24. Lowe SW, Jacks T, Housman DE and Ruley HE. (1994). Proc. Natl. Acad. Sci. USA, 91, 2026-2030.
25. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffmann B and Reed JC. (1994a). Oncogene, 9, 1799-1805.
26. Miyashita T, Harigai M, Hanada M and Reed JC. (1994b). Cancer Res., 54, 3131-3135.
27. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
28. Morgenbesser SD, Williams BO, Jacks T and DePinho RA. (1994). Nature, 371, 72-74.
29. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
30. Olumi AF, Tsai YC, Nichols PW, Skinner DG, Cain DR, Bender LI and Jones PA. (1990). Cancer Res., 50, 7081-7083.
31. Pan H and Griep AE. (1994). Genes Dev., 8, 1285-1299.
32. Pan H and Griep AE. (1995). Genes Dev., 9, 2157-2169.
33. Qin X-Q, Livingston DM, Kaelin Jr WG and Adams PD. (1994). Proc. Natl. Acad. Sci. USA, 91, 10918-10922.
34. Reznikoff CA, Loretz LJ, Pesciotta DM, Oberley TD and Ignjatovic MM. (1987). J. Cell. Physiol., 131, 285-301.
35. Reznikoff CA, Belair C, Savelieva E, Zhai Y, Pfeifer K, Yeager T, Thompson KJ, De Vries S, Bindley C, Newton MA, Sekhon G and Waldman F. (1994). Genes Dev., 8, 2227-2240.
36. Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Blelloch RH, Puthenveettil JA and Cuthill S. (1996). Sem. in Oncol., in press.
37. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
38. Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P and Vogelstein P. (1991). Science, 252, 706-709.
39. Smith ML, Chen I-T, Zhan Q, O'Connor PM and Fornace Jr AJ. (1995). Oncogene, 10, 1053-1059.
40. Spruck III Ch, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R, Dubeau L, Nichols PW, Hermann GG, Steven K, Horm T, Skinner DG and Jones PA. (1994). Cancer Res., 54, 784-788.
41. Teodoro JG, Shore GC and Branton PE. (1995). Oncogene, 11, 467-474.
42. Vousden K. (1993). FASEB J., 7, 872-879.
43. Wagner AJ, Kokontis JM and Hay N. (1994). Genes Dev., 8, 2817-2830.
44. Wazer DE, Liu X-L, Chu Q, Gao Q and Band V. (1995). Proc. Natl. Acad. Sci. USA, 92, 3687-3691.
45. Weinberg RA. (1995). Cell, 81, 323-330.
46. White AE, Livanos EM and Tlsty TD. (1994). Genes Dev., 8, 666-677.
47. Yin DX and Schimke RT. (1996). Proc. Natl. Acad. Sci. USA, 93, 3394-3398.
48. Zambetti GP and Levine AJ. (1993). FASEB J., 7, 855-865.
49. Zhan Q, Fan S, Bae I, Guillouf C, Leibermann DA, O'Connor PM and Fornace Jr AJ. (1994). Oncogene. 9, 3743-3751.
50. zur Hausen H. (1991). Virology, 184, 9-13.